Damir Erceg

466 total citations
30 papers, 235 citations indexed

About

Damir Erceg is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Damir Erceg has authored 30 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Damir Erceg's work include Asthma and respiratory diseases (7 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Neonatal Respiratory Health Research (4 papers). Damir Erceg is often cited by papers focused on Asthma and respiratory diseases (7 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Neonatal Respiratory Health Research (4 papers). Damir Erceg collaborates with scholars based in Croatia, United States and Austria. Damir Erceg's co-authors include Mirjana Turkalj, Günter Gmeiner, Guro Forsdahl, Davor Plavec, Thomas Geisendorfer, Mario Thevis, Laura Tretzel, Dragan Primorac, Slavica Dodig and Lidija Bach‐Rojecky and has published in prestigious journals such as Clinical & Experimental Allergy, Digestive Diseases and Sciences and Steroids.

In The Last Decade

Damir Erceg

27 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Damir Erceg Croatia 9 58 53 49 30 25 30 235
Zhimin Cao United States 11 111 1.9× 23 0.4× 22 0.4× 92 3.1× 17 0.7× 20 306
Xuejiao Wang China 13 27 0.5× 59 1.1× 34 0.7× 125 4.2× 20 0.8× 56 379
Natalie Houwing United Kingdom 8 129 2.2× 21 0.4× 20 0.4× 71 2.4× 130 5.2× 11 550
Karen Walters United States 8 23 0.4× 20 0.4× 113 2.3× 57 1.9× 20 0.8× 14 454
C Prendergast United Kingdom 11 17 0.3× 34 0.6× 49 1.0× 106 3.5× 27 1.1× 22 333
George Kelly United States 9 9 0.2× 45 0.8× 34 0.7× 61 2.0× 30 1.2× 17 220
Claire Brown United States 9 80 1.4× 66 1.2× 80 1.6× 119 4.0× 23 0.9× 20 292
J. Grace van der Gugten Canada 14 166 2.9× 24 0.5× 24 0.5× 98 3.3× 70 2.8× 23 403
D.R. Fahmy United Kingdom 10 186 3.2× 67 1.3× 26 0.5× 79 2.6× 12 0.5× 21 441
Satoko Chiba Japan 11 15 0.3× 23 0.4× 39 0.8× 119 4.0× 18 0.7× 27 362

Countries citing papers authored by Damir Erceg

Since Specialization
Citations

This map shows the geographic impact of Damir Erceg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damir Erceg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damir Erceg more than expected).

Fields of papers citing papers by Damir Erceg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damir Erceg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damir Erceg. The network helps show where Damir Erceg may publish in the future.

Co-authorship network of co-authors of Damir Erceg

This figure shows the co-authorship network connecting the top 25 collaborators of Damir Erceg. A scholar is included among the top collaborators of Damir Erceg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damir Erceg. Damir Erceg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erceg, Damir, et al.. (2024). Conducting Drug Treatment Trials in Children: Opportunities and Challenges. Pharmaceutical Medicine. 38(3). 179–204. 2 indexed citations
2.
Matišić, Vid, Petar Brlek, Vilim Molnar, et al.. (2022). Experience with comprehensive pharmacogenomic multi-gene panel in clinical practice: a retrospective single-center study. Croatian Medical Journal. 63(3). 257–264. 5 indexed citations
3.
4.
Seppä, Ville‐Pekka, et al.. (2020). Expiratory variability index (EVI) is associated with the severity of acute bronchial obstruction in small children: A proof‐of‐concept study. Pediatric Allergy and Immunology. 31(6). 636–642. 5 indexed citations
5.
Primorac, Dragan, Lidija Bach‐Rojecky, Vid Matišić, et al.. (2020). Pharmacogenomics at the Center of Precision Medicine: Challenges and Perspective in an Era of Big Data. Pharmacogenomics. 21(2). 141–156. 30 indexed citations
6.
Primorac, Dragan, et al.. (2020). EFFECTIVE PHARMACOGENOMIC-DRIVEN TREATMENT OF MAJOR DEPRESSION: A CASE REPORT. Psychiatria Danubina. 32(3-4). 428–430. 2 indexed citations
7.
8.
Bach‐Rojecky, Lidija, et al.. (2019). Challenges in Anesthesia Personalization: Resolving the Pharmacogenomic Puzzle. Personalized Medicine. 16(6). 511–525. 7 indexed citations
9.
Turkalj, Mirjana, et al.. (2016). The effect of mouth breathing on exercise induced fall in lung function in children with allergic asthma and rhinitis. International Journal of Pediatric Otorhinolaryngology. 86. 53–56. 8 indexed citations
10.
Plavec, Davor, et al.. (2014). Urates in exhaled breath condensate as a biomarker of control in childhood asthma. Journal of Asthma. 52(5). 437–446. 12 indexed citations
11.
Vidjak, Vinko, et al.. (2013). Pulmonary arteriovenous malformations presenting as difficult-to-control asthma: a case report. Journal of Medical Case Reports. 7(1). 32–32. 7 indexed citations
12.
Turkalj, Mirjana & Damir Erceg. (2012). ALERGIJSKE REAKCIJE NA CJEPIVA. University of Zagreb University Computing Centre (SRCE). 134. 0–0.
13.
Erceg, Damir, et al.. (2012). Inhaled corticosteroids used for the control of asthma in a “real-life” setting do not affect linear growth velocity in prepubertal children. Medical Science Monitor. 18(9). CR564–CR568. 4 indexed citations
14.
Turkalj, Mirjana, Davor Plavec, & Damir Erceg. (2011). Osobitosti astme u djece. University of Zagreb University Computing Centre (SRCE). 20(9). 163–168. 1 indexed citations
15.
Leppée, Marcel, et al.. (2005). Morbidity and mortality in the city of Zagreb, Croatia--health needs and demands.. PubMed. 29(2). 559–65. 1 indexed citations
16.
Erceg, Damir, et al.. (2004). Rational use of benzodiazepines. 1 indexed citations
17.
Banić, Marko, Branimir Anić, Tomislav Brkić, et al.. (2002). Effect of Cyclosporine in a Murine Model of Experimental Colitis. Digestive Diseases and Sciences. 47(6). 1362–1368. 12 indexed citations
18.
Veljača, Marija, et al.. (2001). The development of PL 14736 for treatment of inflammatory bowel disease. Inflammopharmacology. 10. 564–565. 14 indexed citations
19.
Erceg, Damir, et al.. (1997). Some aspects of the effects of PL-10.1.AK-15 on the gastrointestinal tract. Journal of Physiology-Paris. 91(3-5). 179–181. 3 indexed citations
20.
Dodig, Milan, Ivo Rotkvić, Željko Grabarević, et al.. (1993). Pentagastrin Cytoprotection in Ethanol‐Induced Gastric Mucosal Lesions in Rats. Journal of Veterinary Medicine Series A. 40(1-10). 509–515. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhimin Cao Breakdown of academic impact, for papers by Xuejiao Wang Breakdown of academic impact, for papers by Natalie Houwing Breakdown of academic impact, for papers by Karen Walters Breakdown of academic impact, for papers by C Prendergast Breakdown of academic impact, for papers by George Kelly Breakdown of academic impact, for papers by Claire Brown Breakdown of academic impact, for papers by J. Grace van der Gugten Breakdown of academic impact, for papers by D.R. Fahmy Breakdown of academic impact, for papers by Satoko Chiba
Rankless by CCL
2026